Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
about
Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
description
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 12 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@en
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@nl
type
label
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@en
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@nl
prefLabel
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@en
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@nl
P2093
P2860
P1433
P1476
Novel Protein Kinase Inhibitor ...... ciferase Complementation Assay
@en
P2093
Andreas Hilgeroth
Ansgar Opitz
Christoph Schächtele
Frank Totzke
Isabel Hilbrich
Jens Stieler
Moritz Oberstadt
Nico Schade
Valentina Neukel
P2860
P356
10.3390/MOLECULES23092335
P407
P577
2018-09-12T00:00:00Z